Hart Jayne B. 4
4 · MYRIAD GENETICS INC · Filed Mar 1, 2022
Insider Transaction Report
Form 4
Hart Jayne B.
Executive VP Human Resources
Transactions
- Sale
Common Stock
2022-02-28$25.00/sh−3,500$87,500→ 165,878 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2022-02-28−3,500→ 0 totalExercise: $23.98Exp: 2022-03-07→ Common Stock (3,500 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2022-02-28−7,000→ 0 totalExercise: $23.98Exp: 2022-03-07→ Common Stock (7,000 underlying) - Exercise/Conversion
Common Stock
2022-02-28$23.98/sh+3,500$83,930→ 169,378 total - Exercise/Conversion
Common Stock
2022-02-28$23.98/sh+7,000$167,860→ 172,878 total - Sale
Common Stock
2022-02-28$25.00/sh−7,000$175,000→ 165,878 total
Footnotes (3)
- [F1]The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Represents shares of common stock received upon exercise of a stock option award.
- [F3]The shares subject to this option are fully vested and exercisable.